LECO Partners with the Joint Mass Spectrometry Centre
Complete the form below to unlock access to ALL audio articles.
The centre is a cooperative partnership between the University of Rostock and the Helmholtz Zentrum München – German Research Center for Environmental Health.
The Joint Mass Spectrometry Centre will utilize the LECO Citius™ LC-HRT (High Resolution TOFMS) and Pegasus® GC-HRT for applied research in areas such as health-relevant environmental analysis, comprehensive molecular profiling, biomedical and forensic research, and analytical method development. Designed for complex sample analysis, LECO’s HRT instrumentation provides acquisition speeds of up to 200 spectra/second, mass resolution up to 100,000 FWHM, and mass accuracy less than 1 ppm.
The Joint Mass Spectrometry Centre is led by Prof. Dr. Ralf Zimmermann, who also serves as both the chair of analytical chemistry at the University of Rostock and the head of the comprehensive molecular analytics cooperation group at the Helmholtz Zentrum München.
“LECO is honored to support the work of Prof. Dr. Zimmermann and the Joint Mass Spectrometry Centre characterizing complex molecular mixtures,” said Jürgen Wendt, LCMS Technical Product Specialist, LECO European Life Science and Chemical Analysis Centre. “We are confident that his team will significantly benefit from the advantages provided by High Resolution TOFMS.”
The teams at both the Joint Mass Spectrometry Centre and LECO have high expectations for the partnership.
“For the past 10 years at the Helmholtz Zentrum München, we have worked very successfully with GCxGC-TOFMS technology,” said Prof. Dr. Ralf Zimmermann. “In the framework of our most recent cooperation, we are now very much looking forward to new, exciting applications with the novel LECO fast high resolution TOF systems, the GC-HRT and LC-HRT. The new HRT technology platform is perfectly suited for our complex molecular characterisation applications in the field of energy and fuels, environmental research, and metabolomics.”
“My expectation is novel applications of cutting-edge technology,” said Dr. Jeff Patrick, Director of Marketed Technology, LECO Separation Science. “The experience and creativity of Dr. Zimmermann and his team will allow the LECO HRT platform to be highlighted and fully utilized to solve meaningful problems in environmental science, metabolomics, and more. Speaking with Dr. Zimmermann and the scientists at Helmholtz, I’m excited about the possibilities, and I think other scientists will be just as excited about the outcomes.”
